25 XP   0   0   10

IX BIOPHARMA LTD.
Buy, Hold or Sell?

Let's analyse IX BIOPHARMA LTD. together

PenkeI guess you are interested in IX BIOPHARMA LTD.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of IX BIOPHARMA LTD.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about IX BIOPHARMA LTD.

I send you an email if I find something interesting about IX BIOPHARMA LTD..

Quick analysis of IX BIOPHARMA LTD. (30 sec.)










What can you expect buying and holding a share of IX BIOPHARMA LTD.? (30 sec.)

How much money do you get?

How much money do you get?
S$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
S$0.02
Expected worth in 1 year
S$0.00
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
S$-0.02
Return On Investment
-47.1%

For what price can you sell your share?

Current Price per Share
S$0.04
Expected price per share
S$0.037 - S$0.041
How sure are you?
50%

1. Valuation of IX BIOPHARMA LTD. (5 min.)




Live pricePrice per Share (EOD)

S$0.04

Intrinsic Value Per Share

S$-0.06 - S$-0.03

Total Value Per Share

S$-0.04 - S$-0.01

2. Growth of IX BIOPHARMA LTD. (5 min.)




Is IX BIOPHARMA LTD. growing?

Current yearPrevious yearGrowGrow %
How rich?$11.6m$14.4m-$2.8m-24.6%

How much money is IX BIOPHARMA LTD. making?

Current yearPrevious yearGrowGrow %
Making money-$7m-$3.3m-$3.6m-52.2%
Net Profit Margin-162.6%-32.0%--

How much money comes from the company's main activities?

3. Financial Health of IX BIOPHARMA LTD. (5 min.)




What can you expect buying and holding a share of IX BIOPHARMA LTD.? (5 min.)

Welcome investor! IX BIOPHARMA LTD.'s management wants to use your money to grow the business. In return you get a share of IX BIOPHARMA LTD..

What can you expect buying and holding a share of IX BIOPHARMA LTD.?

First you should know what it really means to hold a share of IX BIOPHARMA LTD.. And how you can make/lose money.

Speculation

The Price per Share of IX BIOPHARMA LTD. is S$0.043. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of IX BIOPHARMA LTD..
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in IX BIOPHARMA LTD., you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is S$0.02. Based on the TTM, the Book Value Change Per Share is S$-0.01 per quarter. Based on the YOY, the Book Value Change Per Share is S$0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is S$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of IX BIOPHARMA LTD..

How much money are you going to get?

 MRQTTMYOY5Y10Y
 S$% of Price per ShareS$% of Price per ShareS$% of Price per ShareS$% of Price per ShareS$% of Price per Share
Usd Eps-0.01-21.4%-0.01-21.4%0.00-10.2%-0.01-16.0%-0.01-17.7%
Usd Book Value Change Per Share0.00-8.7%0.00-8.7%0.0117.9%0.00-2.5%0.003.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.00-8.7%0.00-8.7%0.0117.9%0.00-2.5%0.003.5%
Usd Price Per Share0.07-0.07-0.12-0.15-0.13-
Price to Earnings Ratio-7.27--7.27--27.24--28.14--20.39-
Price-to-Total Gains Ratio-17.96--17.96-15.59--18.67--21.83-
Price to Book Ratio4.41-4.41-6.34-10.99-7.22-
Price-to-Total Gains Ratio-17.96--17.96-15.59--18.67--21.83-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0315749
Number of shares31670
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (31670 shares)-117.80-34.31
Gains per Year (31670 shares)-471.21-137.25
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-471-4810-137-147
20-942-9520-274-284
30-1414-14230-412-421
40-1885-18940-549-558
50-2356-23650-686-695
60-2827-28360-823-832
70-3298-33070-961-969
80-3770-37780-1098-1106
90-4241-42490-1235-1243
100-4712-47200-1372-1380

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.010.00.00.0%
Book Value Change Per Share0.01.00.00.0%2.01.00.066.7%2.03.00.040.0%4.06.00.040.0%4.06.00.040.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.010.00.0%
Total Gains per Share0.01.00.00.0%2.01.00.066.7%2.03.00.040.0%4.06.00.040.0%4.06.00.040.0%

Fundamentals of IX BIOPHARMA LTD.

About IX BIOPHARMA LTD.

iX Biopharma Ltd., a specialty pharmaceutical and nutraceutical company, develops, manufactures, and commercializes therapies for the treatment of acute and breakthrough pain, and other health conditions in Singapore, Europe, the United States, China, and Australia. The company operates through Pharmaceutical and Nutraceutical segments. It offers Wafermine, a sublingual ketamine wafer, which has completed phase-2 clinical trial for the treatment of acute moderate to severe pain and complex regional pain syndrome; Xativa, a sublingual cannabidiol wafer, as well as Hypera, a tetrahydrocannabinol sublingual wafer for the treatment of anxiety, chronic pain, inflammation, and insomnia; and Wafesil and Silcap for the treatment of male erectile dysfunction. The company also provides LumeniX, a sublingual glutathione wafer for skin brightening and immunity; Radiance for reducing wrinkles, smoothening the skin, and promoting a youthful complexion; Regenerate that supports cellular health and aids energy production; WafeRest for the alleviating jetlag and promotion of sleep; and SL-NAD+ supplement products. In addition, it is involved in the development BnoX, a sublingual buprenorphine wafer that is in a phase-1 clinical trial for the management of moderate to severe pain; Dexmedetomidine, which has completed phase-1 clinical trial for agitation in dementia patients; Dronabinol for chemotherapy-induced nausea, vomiting, and anorexia associated with weight loss in patients with HIV/AIDS; IXB-214, which is in phase-1 clinical trial for the treatment of complex regional pain syndrome; IXB-314 that is in phase-1 clinical trial for the treatment-resistant depression; IXB-321, a sublingual vaccine wafer; iXB-322 for respiratory viral prophylaxis; and iXB-320 for anorexia in HIV/chemoinduced nausea and vomiting. iX Biopharma Ltd. was incorporated in 2004 and is headquartered in Singapore.

Fundamental data was last updated by Penke on 2024-04-16 22:17:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of IX BIOPHARMA LTD..

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit IX BIOPHARMA LTD. earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare IX BIOPHARMA LTD. to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -162.6% means that $-1.63 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of IX BIOPHARMA LTD.:

  • The MRQ is -162.6%. The company is making a huge loss. -2
  • The TTM is -162.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-162.6%TTM-162.6%0.0%
TTM-162.6%YOY-32.0%-130.7%
TTM-162.6%5Y-435.6%+273.0%
5Y-435.6%10Y-890.2%+454.6%
1.1.2. Return on Assets

Shows how efficient IX BIOPHARMA LTD. is using its assets to generate profit.

  • Above 5% is considered healthy but always compare IX BIOPHARMA LTD. to the Drug Manufacturers - Specialty & Generic industry mean.
  • -38.6% Return on Assets means that IX BIOPHARMA LTD. generated $-0.39 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of IX BIOPHARMA LTD.:

  • The MRQ is -38.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -38.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-38.6%TTM-38.6%0.0%
TTM-38.6%YOY-16.1%-22.4%
TTM-38.6%5Y-34.3%-4.3%
5Y-34.3%10Y-33.5%-0.8%
1.1.3. Return on Equity

Shows how efficient IX BIOPHARMA LTD. is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare IX BIOPHARMA LTD. to the Drug Manufacturers - Specialty & Generic industry mean.
  • -60.7% Return on Equity means IX BIOPHARMA LTD. generated $-0.61 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of IX BIOPHARMA LTD.:

  • The MRQ is -60.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -60.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-60.7%TTM-60.7%0.0%
TTM-60.7%YOY-23.3%-37.4%
TTM-60.7%5Y-54.4%-6.2%
5Y-54.4%10Y-51.0%-3.4%

1.2. Operating Efficiency of IX BIOPHARMA LTD..

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient IX BIOPHARMA LTD. is operating .

  • Measures how much profit IX BIOPHARMA LTD. makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare IX BIOPHARMA LTD. to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of -161.4% means the company generated $-1.61  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of IX BIOPHARMA LTD.:

  • The MRQ is -161.4%. The company is operating very inefficient. -2
  • The TTM is -161.4%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-161.4%TTM-161.4%0.0%
TTM-161.4%YOY3.5%-164.9%
TTM-161.4%5Y-751.0%+589.6%
5Y-751.0%10Y-1,070.0%+318.9%
1.2.2. Operating Ratio

Measures how efficient IX BIOPHARMA LTD. is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 3.22 means that the operating costs are $3.22 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of IX BIOPHARMA LTD.:

  • The MRQ is 3.216. The company is inefficient in keeping operating costs low. -1
  • The TTM is 3.216. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ3.216TTM3.2160.000
TTM3.216YOY1.108+2.107
TTM3.2165Y9.395-6.179
5Y9.39510Y14.871-5.476

1.3. Liquidity of IX BIOPHARMA LTD..

1.3. Liquidity
1.3.1. Current Ratio

Measures if IX BIOPHARMA LTD. is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.53 means the company has $1.53 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of IX BIOPHARMA LTD.:

  • The MRQ is 1.530. The company is able to pay all its short-term debts. +1
  • The TTM is 1.530. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.530TTM1.5300.000
TTM1.530YOY2.144-0.614
TTM1.5305Y3.201-1.671
5Y3.20110Y4.529-1.327
1.3.2. Quick Ratio

Measures if IX BIOPHARMA LTD. is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare IX BIOPHARMA LTD. to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.17 means the company can pay off $0.17 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of IX BIOPHARMA LTD.:

  • The MRQ is 0.174. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.174. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.174TTM0.1740.000
TTM0.174YOY0.064+0.110
TTM0.1745Y1.781-1.607
5Y1.78110Y3.337-1.555

1.4. Solvency of IX BIOPHARMA LTD..

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of IX BIOPHARMA LTD. assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare IX BIOPHARMA LTD. to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.36 means that IX BIOPHARMA LTD. assets are financed with 36.4% credit (debt) and the remaining percentage (100% - 36.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of IX BIOPHARMA LTD.:

  • The MRQ is 0.364. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.364. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.364TTM0.3640.000
TTM0.364YOY0.308+0.056
TTM0.3645Y0.337+0.027
5Y0.33710Y0.305+0.031
1.4.2. Debt to Equity Ratio

Measures if IX BIOPHARMA LTD. is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare IX BIOPHARMA LTD. to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 57.3% means that company has $0.57 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of IX BIOPHARMA LTD.:

  • The MRQ is 0.573. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.573. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.573TTM0.5730.000
TTM0.573YOY0.444+0.128
TTM0.5735Y0.520+0.053
5Y0.52010Y0.456+0.064

2. Market Valuation of IX BIOPHARMA LTD.

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings IX BIOPHARMA LTD. generates.

  • Above 15 is considered overpriced but always compare IX BIOPHARMA LTD. to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -7.27 means the investor is paying $-7.27 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of IX BIOPHARMA LTD.:

  • The EOD is -3.436. Based on the earnings, the company is expensive. -2
  • The MRQ is -7.272. Based on the earnings, the company is expensive. -2
  • The TTM is -7.272. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.436MRQ-7.272+3.836
MRQ-7.272TTM-7.2720.000
TTM-7.272YOY-27.237+19.965
TTM-7.2725Y-28.140+20.869
5Y-28.14010Y-20.394-7.746
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of IX BIOPHARMA LTD.:

  • The EOD is -3.954. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -8.368. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -8.368. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.954MRQ-8.368+4.414
MRQ-8.368TTM-8.3680.000
TTM-8.368YOY42.845-51.213
TTM-8.3685Y-3.884-4.484
5Y-3.88410Y-9.201+5.317
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of IX BIOPHARMA LTD. is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of IX BIOPHARMA LTD.:

  • The EOD is 2.084. Based on the equity, the company is underpriced. +1
  • The MRQ is 4.411. Based on the equity, the company is fair priced.
  • The TTM is 4.411. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD2.084MRQ4.411-2.326
MRQ4.411TTM4.4110.000
TTM4.411YOY6.343-1.932
TTM4.4115Y10.989-6.579
5Y10.98910Y7.224+3.766
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of IX BIOPHARMA LTD. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.005-0.0050%0.010-148%-0.001-71%0.002-346%
Book Value Per Share--0.0210.0210%0.026-20%0.020+2%0.026-19%
Current Ratio--1.5301.5300%2.144-29%3.201-52%4.529-66%
Debt To Asset Ratio--0.3640.3640%0.308+18%0.337+8%0.305+19%
Debt To Equity Ratio--0.5730.5730%0.444+29%0.520+10%0.456+26%
Dividend Per Share----0%-0%-0%-0%
Eps---0.013-0.0130%-0.006-52%-0.009-25%-0.010-17%
Free Cash Flow Per Share---0.011-0.0110%0.004-386%-0.010-6%-0.010-12%
Free Cash Flow To Equity Per Share---0.009-0.0090%0.017-155%-0.005-41%-0.001-90%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---0.034--------
Intrinsic Value_10Y_min---0.064--------
Intrinsic Value_1Y_max---0.006--------
Intrinsic Value_1Y_min---0.009--------
Intrinsic Value_3Y_max---0.015--------
Intrinsic Value_3Y_min---0.026--------
Intrinsic Value_5Y_max---0.023--------
Intrinsic Value_5Y_min---0.039--------
Market Cap33037630.656-112%69916846.27269916846.2720%125235669.696-44%153509735.002-54%131074878.835-47%
Net Profit Margin---1.626-1.6260%-0.320-80%-4.356+168%-8.902+447%
Operating Margin---1.614-1.6140%0.035-4736%-7.510+365%-10.700+563%
Operating Ratio--3.2163.2160%1.108+190%9.395-66%14.871-78%
Pb Ratio2.084-112%4.4114.4110%6.343-30%10.989-60%7.224-39%
Pe Ratio-3.436+53%-7.272-7.2720%-27.237+275%-28.140+287%-20.394+180%
Price Per Share0.043-112%0.0910.0910%0.163-44%0.200-54%0.171-47%
Price To Free Cash Flow Ratio-3.954+53%-8.368-8.3680%42.845-120%-3.884-54%-9.201+10%
Price To Total Gains Ratio-8.489+53%-17.964-17.9640%15.590-215%-18.671+4%-21.831+22%
Quick Ratio--0.1740.1740%0.064+172%1.781-90%3.337-95%
Return On Assets---0.386-0.3860%-0.161-58%-0.343-11%-0.335-13%
Return On Equity---0.607-0.6070%-0.233-62%-0.544-10%-0.510-16%
Total Gains Per Share---0.005-0.0050%0.010-148%-0.001-71%0.002-346%
Usd Book Value--11640123.60011640123.6000%14498019.200-20%11451261.640+2%14417686.780-19%
Usd Book Value Change Per Share---0.004-0.0040%0.008-148%-0.001-71%0.002-346%
Usd Book Value Per Share--0.0150.0150%0.019-20%0.015+2%0.019-19%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.009-0.0090%-0.004-52%-0.007-25%-0.008-17%
Usd Free Cash Flow---6135076.500-6135076.5000%2146358.900-386%-5762786.400-6%-5397692.440-12%
Usd Free Cash Flow Per Share---0.008-0.0080%0.003-386%-0.008-6%-0.007-12%
Usd Free Cash Flow To Equity Per Share---0.007-0.0070%0.012-155%-0.004-41%-0.001-90%
Usd Market Cap24259532.191-112%51339940.21851339940.2180%91960552.258-44%112722198.412-54%96248283.529-47%
Usd Price Per Share0.032-112%0.0670.0670%0.120-44%0.147-54%0.125-47%
Usd Profit---7060294.500-7060294.5000%-3376311.400-52%-5277707.820-25%-5853692.740-17%
Usd Revenue--4341915.9004341915.9000%10566577.000-59%3481169.440+25%3312133.580+31%
Usd Total Gains Per Share---0.004-0.0040%0.008-148%-0.001-71%0.002-346%
 EOD+3 -5MRQTTM+0 -0YOY+4 -295Y+11 -2210Y+7 -26

3.2. Fundamental Score

Let's check the fundamental score of IX BIOPHARMA LTD. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-3.436
Price to Book Ratio (EOD)Between0-12.084
Net Profit Margin (MRQ)Greater than0-1.626
Operating Margin (MRQ)Greater than0-1.614
Quick Ratio (MRQ)Greater than10.174
Current Ratio (MRQ)Greater than11.530
Debt to Asset Ratio (MRQ)Less than10.364
Debt to Equity Ratio (MRQ)Less than10.573
Return on Equity (MRQ)Greater than0.15-0.607
Return on Assets (MRQ)Greater than0.05-0.386
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of IX BIOPHARMA LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.631
Ma 20Greater thanMa 500.049
Ma 50Greater thanMa 1000.045
Ma 100Greater thanMa 2000.044
OpenGreater thanClose0.040
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in SGD. All numbers in thousands.

Summary
Total Assets24,928
Total Liabilities9,076
Total Stockholder Equity15,852
 As reported
Total Liabilities 9,076
Total Stockholder Equity+ 15,852
Total Assets = 24,928

Assets

Total Assets24,928
Total Current Assets10,979
Long-term Assets13,949
Total Current Assets
Cash And Cash Equivalents 6,519
Net Receivables 1,250
Inventory 956
Total Current Assets  (as reported)10,979
Total Current Assets  (calculated)8,725
+/- 2,254
Long-term Assets
Property Plant Equipment 8,218
Goodwill 291
Other Assets 1,567
Long-term Assets  (as reported)13,949
Long-term Assets  (calculated)10,076
+/- 3,873

Liabilities & Shareholders' Equity

Total Current Liabilities7,175
Long-term Liabilities1,901
Total Stockholder Equity15,852
Total Current Liabilities
Short Long Term Debt 2,751
Accounts payable 395
Other Current Liabilities 781
Total Current Liabilities  (as reported)7,175
Total Current Liabilities  (calculated)3,927
+/- 3,248
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt1,019
Other Liabilities 755
Long-term Liabilities  (as reported)1,901
Long-term Liabilities  (calculated)1,774
+/- 127
Total Stockholder Equity
Common Stock97,233
Retained Earnings -86,183
Other Stockholders Equity 4,802
Total Stockholder Equity (as reported)15,852
Total Stockholder Equity (calculated)15,852
+/-0
Other
Capital Stock97,233
Common Stock Shares Outstanding 766,300
Net Invested Capital 19,171
Net Tangible Assets 15,561
Net Working Capital 3,804
Property Plant and Equipment Gross 12,738



Balance Sheet

Currency in SGD. All numbers in thousands.

 Trend2023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-30
> Total Assets 
18,823
15,400
46,110
44,250
33,074
26,686
16,982
18,857
28,517
24,928
24,92828,51718,85716,98226,68633,07444,25046,11015,40018,823
   > Total Current Assets 
13,299
10,935
36,753
34,582
24,113
18,509
8,143
9,351
16,843
10,979
10,97916,8439,3518,14318,50924,11334,58236,75310,93513,299
       Cash And Cash Equivalents 
12,083
8,891
31,327
31,088
21,066
15,872
5,663
6,205
13,494
6,519
6,51913,4946,2055,66315,87221,06631,08831,3278,89112,083
       Short-term Investments 
27
51
325
336
144
29
0
0
0
0
0000291443363255127
       Net Receivables 
1,185
1,326
820
2,973
2,033
1,425
149
222
504
1,250
1,2505042221491,4252,0332,9738201,3261,185
       Other Current Assets 
0
84
325
336
486
362
297
227
462
0
0462227297362486336325840
   > Long-term Assets 
0
0
9,357
9,668
8,961
8,177
8,839
9,506
11,674
13,949
13,94911,6749,5068,8398,1778,9619,6689,35700
       Property Plant Equipment 
2,588
2,169
7,541
8,191
8,096
7,636
8,287
8,945
7,724
8,218
8,2187,7248,9458,2877,6368,0968,1917,5412,1692,588
       Goodwill 
381
335
325
343
327
308
310
327
310
291
291310327310308327343325335381
       Intangible Assets 
2,555
1,901
1,468
1,055
538
152
137
86
36
0
036861371525381,0551,4681,9012,555
       Other Assets 
0
60
23
79
0
81
105
148
1,343
1,567
1,5671,3431481058107923600
> Total Liabilities 
6,031
5,156
7,919
8,625
11,554
6,187
6,814
7,146
8,773
9,076
9,0768,7737,1466,8146,18711,5548,6257,9195,1566,031
   > Total Current Liabilities 
3,733
4,104
3,421
3,873
7,132
2,531
3,297
3,667
7,855
7,175
7,1757,8553,6673,2972,5317,1323,8733,4214,1043,733
       Short-term Debt 
1,618
84
207
271
285
211
0
0
0
0
0000211285271207841,618
       Short Long Term Debt 
1,618
84
207
271
285
211
216
421
3,291
2,751
2,7513,291421216211285271207841,618
       Accounts payable 
394
600
3,063
877
3,618
466
848
550
224
395
3952245508484663,6188773,063600394
       Other Current Liabilities 
976
1,258
181
277
190
97
21
15
1,797
781
7811,7971521971902771811,258976
   > Long-term Liabilities 
0
0
4,498
4,752
4,422
3,656
3,517
3,479
918
1,901
1,9019183,4793,5173,6564,4224,7524,49800
       Long term Debt Total 
0
397
4,045
4,480
4,254
3,620
3,457
0
0
0
0003,4573,6204,2544,4804,0453970
       Capital Lease Obligations 
0
0
0
0
0
0
264
613
238
1,019
1,019238613264000000
       Long-term Liabilities Other 
0
0
0
0
17
0
0
0
0
0
00000170000
> Total Stockholder Equity
12,792
10,244
38,191
35,625
21,520
20,499
10,168
11,711
19,744
15,852
15,85219,74411,71110,16820,49921,52035,62538,19110,24412,792
   Common Stock
21,438
29,019
64,998
70,131
71,129
71,525
72,251
83,337
94,178
97,233
97,23394,17883,33772,25171,52571,12970,13164,99829,01921,438
   Retained Earnings -86,183-76,568-71,970-63,736-53,237-50,246-35,152-27,318-18,760-9,498
   Capital Surplus 0000000000
   Treasury Stock0000000000
   Other Stockholders Equity 
852
-15
511
646
637
2,211
1,653
344
2,134
4,802
4,8022,1343441,6532,211637646511-15852



Balance Sheet

Currency in SGD. All numbers in thousands.




Cash Flow

Currency in SGD. All numbers in thousands.




Income Statement

Currency in SGD. All numbers in thousands.


Latest Income Statement (annual, 2023-06-30)

Gross Profit (+$)
totalRevenue5,913
Cost of Revenue-3,593
Gross Profit2,3202,320
 
Operating Income (+$)
Gross Profit2,320
Operating Expense-15,422
Operating Income-9,509-13,102
 
Operating Expense (+$)
Research Development2,820
Selling General Administrative9,044
Selling And Marketing Expenses0
Operating Expense15,42211,864
 
Net Interest Income (+$)
Interest Income7
Interest Expense-271
Other Finance Cost-0
Net Interest Income-264
 
Pretax Income (+$)
Operating Income-9,509
Net Interest Income-264
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-9,706-9,509
EBIT - interestExpense = -9,815
-9,706
-9,344
Interest Expense271
Earnings Before Interest and Taxes (EBIT)-9,544-9,435
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-9,706
Tax Provision--91
Net Income From Continuing Ops-9,615-9,615
Net Income-9,615
Net Income Applicable To Common Shares-9,615
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0264
 

Technical Analysis of IX BIOPHARMA LTD.
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of IX BIOPHARMA LTD.. The general trend of IX BIOPHARMA LTD. is BEARISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine IX BIOPHARMA LTD.'s overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-28.6%) Bearish trend (28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of IX BIOPHARMA LTD..

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.041 < 0.041 < 0.041.

The bearish price targets are: 0.039 > 0.039 > 0.037.

Tweet this
IX BIOPHARMA LTD. Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of IX BIOPHARMA LTD.. The current mas is .

The long score for the Moving Averages is 5/14.
The longshort score for the Moving Averages is -4/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

IX BIOPHARMA LTD. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of IX BIOPHARMA LTD.. The current macd is -0.00042432.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the IX BIOPHARMA LTD. price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for IX BIOPHARMA LTD.. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the IX BIOPHARMA LTD. price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
IX BIOPHARMA LTD. Daily Moving Average Convergence/Divergence (MACD) ChartIX BIOPHARMA LTD. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of IX BIOPHARMA LTD.. The current adx is 36.06.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell IX BIOPHARMA LTD. shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
IX BIOPHARMA LTD. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of IX BIOPHARMA LTD.. The current sar is 0.05314055.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
IX BIOPHARMA LTD. Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of IX BIOPHARMA LTD.. The current rsi is 43.63. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
IX BIOPHARMA LTD. Daily Relative Strength Index (RSI) ChartIX BIOPHARMA LTD. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of IX BIOPHARMA LTD.. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the IX BIOPHARMA LTD. price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
IX BIOPHARMA LTD. Daily Stochastic Oscillator ChartIX BIOPHARMA LTD. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of IX BIOPHARMA LTD.. The current cci is -151.83752418.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
IX BIOPHARMA LTD. Daily Commodity Channel Index (CCI) ChartIX BIOPHARMA LTD. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of IX BIOPHARMA LTD.. The current cmo is -18.41299415.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
IX BIOPHARMA LTD. Daily Chande Momentum Oscillator (CMO) ChartIX BIOPHARMA LTD. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of IX BIOPHARMA LTD.. The current willr is -70.58823529.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that IX BIOPHARMA LTD. is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
IX BIOPHARMA LTD. Daily Williams %R ChartIX BIOPHARMA LTD. Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of IX BIOPHARMA LTD..

IX BIOPHARMA LTD. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of IX BIOPHARMA LTD.. The current atr is 0.00313165.

IX BIOPHARMA LTD. Daily Average True Range (ATR) ChartIX BIOPHARMA LTD. Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of IX BIOPHARMA LTD.. The current obv is -3,604,700.

IX BIOPHARMA LTD. Daily On-Balance Volume (OBV) ChartIX BIOPHARMA LTD. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of IX BIOPHARMA LTD.. The current mfi is 41.88.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
IX BIOPHARMA LTD. Daily Money Flow Index (MFI) ChartIX BIOPHARMA LTD. Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for IX BIOPHARMA LTD..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-29CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-18MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-20CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-26WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-15STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-22MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-31DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-13MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-16MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-26MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-06STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-02RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-04STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-18ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

IX BIOPHARMA LTD. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of IX BIOPHARMA LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.631
Ma 20Greater thanMa 500.049
Ma 50Greater thanMa 1000.045
Ma 100Greater thanMa 2000.044
OpenGreater thanClose0.040
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of IX BIOPHARMA LTD. with someone you think should read this too:
  • Are you bullish or bearish on IX BIOPHARMA LTD.? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about IX BIOPHARMA LTD.? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about IX BIOPHARMA LTD.

I send you an email if I find something interesting about IX BIOPHARMA LTD..


Comments

How you think about this?

Leave a comment

Stay informed about IX BIOPHARMA LTD..

Receive notifications about IX BIOPHARMA LTD. in your mailbox!